While researchers pursue high-cost remedies for rare ailments, development of broadly useful drugs like antibiotics is lagging.
By EDUARDO PORTER, NY Times: Business
Tue, 07/22/2014 - 3:02pm
While researchers pursue high-cost remedies for rare ailments, development of broadly useful drugs like antibiotics is lagging.